Ozempic does not “force” a caloric deficit like a cattle prod. It changes appetite signaling, satiety, gastric emptying, insulin secretion, glucagon, and in many patients improves glycemic control, fatty liver markers, and cardiometabolic risk. That is metabolism.
The phrase “chemical crutch” is just moralizing in a lab coat. We do not call insulin a crutch, or antihypertensives a crutch, or glasses a crutch. We call them treatment.
And this obsession with “root cause” is usually a racket. Obesity and metabolic disease are not one thing with one sacred origin story. They are genetics, appetite regulation, food environment, insulin resistance, sleep, medications, activity, and yes, inflammation. GLP-1 drugs act on several of those pathways at once.
So no, this is not merely appetite suppression while the “real problem” hides in the basement. It is treatment of the very systems that are dysregulated. The scale is not the only outcome, but pretending improved blood sugar, less visceral fat, and better metabolic function do not count because a drug was involved is ideology, not medicine.
Ozempic isn’t fixing your metabolism, it’s suppressing your appetite while the root cause stays untouched.
By mimicking hunger-regulating hormones, these injections induce significant appetite suppression and delayed gastric emptying, effectively forcing a caloric deficit.
However, this exogenous intervention does little to resolve the underlying biochemical signaling issues or the cellular inflammation that drives weight gain in the first place.
When the focus remains solely on the scale rather than restoring metabolic flexibility, the body remains dependent on a chemical crutch while the root cause often rooted in hyperinsulinemia and poor mitochondrial function continues to simmer beneath the surface.